✦ LIBER ✦

Tumor Progression and Therapeutic Resistance: An Overview

✍ Scribed by LINDA HOTCHKISS MEHTA

Book ID: 111479231
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 37 KB
Volume: 1059
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1339.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer stem cells: A new paradigm for un

Cancer stem cells: A new paradigm for understanding tumor progression and therapeutic resistance

✍ Emina H. Huang; David G. Heidt; Chen-Wei Li; Diane M. Simeone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 862 KB

Therapeutic Action: An Introduction and

Therapeutic Action: An Introduction and Overview

✍ Frank, Kenneth A.; Bernstein, Kim 📂 Article 📅 2012 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 130 KB

HIF-1 and tumor progression: pathophysio

HIF-1 and tumor progression: pathophysiology and therapeutics

✍ Gregg L. Semenza 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 316 KB

HIF-1 and tumor progression: pathophysio

HIF-1 and tumor progression: pathophysiology and therapeutics

✍ Gregg L. Semenza 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Hypoxia-inducible factor 1 (HIF-1) controls oxygen delivery (via angiogenesis) and metabolic adaptation to hypoxia (via glycolysis). HIF-1 consists of a constitutively expressed HIF-1β subunit and an oxygen-and growth-factor-regulated HIF-1α subunit. In xenografts, tumor growth and angiogenesis are

AN OVERVIEW OF THERAPEUTIC APHERESIS

✍ H. BORBERG 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 966 KB

Targeting tumor cell resistance to apopt

Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential

✍ Robet.A. Olie; Uwe Zangemeister-Wittke 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 171 KB